GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us
- PMID: 11765119
- DOI: 10.3949/ccjm.68.12.1017
GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us
Abstract
Recent clinical trials have refined our understanding of how the glycoprotein (GP) IIb/IIIa inhibitors should best be used. These trials examined whether there are clinical differences between agents, whether empiric use of GP IIb/IIIa inhibitors in acute coronary syndromes is justified, and whether these drugs might allow for early invasive management in acute coronary syndromes.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical